Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Aug-24 5:28 PM View:  | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 10-Jul-24 | Payment of Exercise | 271 | $1.71 | $463.41 | (< 1%) 29.33K to 29.06K | |
| 02-Aug-24 5:34 PM View: | Bigora Sian Chief Development Officer | Processa Pharmaceuticals, I... (PCSA) | 10-Jul-24 | Payment of Exercise | 225 | $1.71 | $384.75 | (< 1%) 28.77K to 28.55K | |
| 02-Aug-24 5:31 PM View: | Stanker James H Chief Financial Officer | Processa Pharmaceuticals, I... (PCSA) | 10-Jul-24 | Option Exercise | 644 | -- | -- | 11% 6.12K to 6.76K | |
| 02-Aug-24 5:31 PM View: | Stanker James H Chief Financial Officer | Processa Pharmaceuticals, I... (PCSA) | 10-Jul-24 | Payment of Exercise | 282 | $1.71 | $482.22 | (4%) 6.76K to 6.48K | |
| 02-Aug-24 5:28 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 10-Jul-24 | Option Exercise | 644 | -- | -- | 2% 28.69K to 29.33K | |
| 02-Aug-24 5:34 PM View: | Bigora Sian Chief Development Officer | Processa Pharmaceuticals, I... (PCSA) | 10-Jul-24 | Option Exercise | 644 | -- | -- | 2% 28.13K to 28.77K | |
| 02-Aug-24 5:31 PM View: | Stanker James H Chief Financial Officer | Processa Pharmaceuticals, I... (PCSA) | 05-Apr-24 | Option Exercise | 1,675 | -- | -- | 34% 4.96K to 6.64K | |
| 02-Aug-24 5:31 PM View: | Stanker James H Chief Financial Officer | Processa Pharmaceuticals, I... (PCSA) | 05-Apr-24 | Payment of Exercise | 518 | $2.79 | $1,445.22 | (8%) 6.64K to 6.12K | |
| 02-Aug-24 5:28 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 05-Apr-24 | Option Exercise | 1,675 | -- | -- | 6% 27.55K to 29.23K | |
| 02-Aug-24 5:34 PM View: | Bigora Sian Chief Development Officer | Processa Pharmaceuticals, I... (PCSA) | 05-Apr-24 | Option Exercise | 1,675 | -- | -- | 6% 26.82K to 28.5K | |
| 02-Aug-24 5:28 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 05-Apr-24 | Payment of Exercise | 539 | $2.79 | $1,503.81 | (2%) 29.23K to 28.69K | |
| 02-Aug-24 5:34 PM View: | Bigora Sian Chief Development Officer | Processa Pharmaceuticals, I... (PCSA) | 05-Apr-24 | Payment of Exercise | 368 | $2.79 | $1,026.72 | (1%) 28.5K to 28.13K | |
| 08-Feb-24 4:30 PM View: | Young David Pres. Research & Development Director | Processa Pharmaceuticals, I... (PCSA) | 07-Feb-24 | Private Purchase | 21,000 | $2.45 | $51,525.60 | 18% 118.7K to 139.7K | |
| 07-Feb-24 4:22 PM View: | Young David Pres. Research & Development Director | Processa Pharmaceuticals, I... (PCSA) | 06-Feb-24 | Private Purchase | 20,000 | $2.53 | $50,504.00 | 20% 98.7K to 118.7K | |
| 01-Feb-24 6:32 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 01-Feb-24 | Purchase | 1,500 | $2.40 | $3,600.00 | 6% 25.98K to 27.48K | |
| 01-Feb-24 6:32 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 31-Jan-24 | Private Purchase | 2,500 | $2.37 | $5,925.00 | 11% 23.48K to 25.98K | |
| 31-Jan-24 4:37 PM View: | Ng George K Chief Executive Officer Director | Processa Pharmaceuticals, I... (PCSA) | 30-Jan-24 | Private Purchase | 10,000 | $2.70 | $27,000.00 | 100% 10.0K to 20.0K | |
| 31-Jan-24 4:34 PM View: | Yorke Justin W Director | Processa Pharmaceuticals, I... (PCSA) | 30-Jan-24 | Private Purchase | 8,000 | $2.69 | $21,544.00 | 30% 26.97K to 34.97K | |
| 12-Apr-24 4:57 PM View: | Stanker James H Chief Financial Officer | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Option Exercise | 1,675 | -- | -- | 34% 4.96K to 6.64K | |
| 12-Apr-24 4:52 PM View: | Bigora Sian Chief Development Officer | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Payment of Exercise | 368 | $2.79 | $1,026.72 | (1%) 28.49K to 28.13K | |
| 12-Apr-24 4:50 PM View: | Guy Wendy Chief Administrative Officer | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Option Exercise | 1,675 | -- | -- | 9% 18.46K to 20.14K | |
| 12-Apr-24 5:01 PM View: | Young David Pres. Research & Development Director | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Payment of Exercise | 518 | $2.79 | $1,445.22 | (< 1%) 141.38K to 140.86K | |
| 12-Apr-24 4:55 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Payment of Exercise | 539 | $2.79 | $1,503.81 | (2%) 29.15K to 28.61K | |
| 12-Apr-24 4:52 PM View: | Bigora Sian Chief Development Officer | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Option Exercise | 1,675 | -- | -- | 6% 26.82K to 28.49K | |
| 12-Apr-24 5:01 PM View: | Young David Pres. Research & Development Director | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Option Exercise | 1,675 | -- | -- | 1% 139.7K to 141.38K | |
| 12-Apr-24 4:57 PM View: | Stanker James H Chief Financial Officer | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Payment of Exercise | 518 | $2.79 | $1,445.22 | (8%) 6.64K to 6.12K | |
| 12-Apr-24 4:55 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Option Exercise | 1,675 | -- | -- | 6% 27.48K to 29.15K | |
| 12-Apr-24 4:50 PM View: | Guy Wendy Chief Administrative Officer | Processa Pharmaceuticals, I... (PCSA) | 01-Jan-24 | Payment of Exercise | 368 | $2.79 | $1,026.72 | (2%) 20.14K to 19.77K | |
| 28-Nov-23 4:13 PM View: | Yorke Justin W Director | Processa Pharmaceuticals, I... (PCSA) | 21-Nov-23 | Disposition (other) | 55,267 | -- | -- | (9%) 594.62K to 539.35K | |
| 12-Oct-23 6:01 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 12-Oct-23 | Grant | 5,000 | $0.32 | $1,600.00 | 1% 464.54K to 469.54K | |
| 12-Oct-23 5:58 PM View: | Stanker James H Chief Financial Officer | Processa Pharmaceuticals, I... (PCSA) | 12-Oct-23 | Grant | 15,000 | $0.33 | $4,950.00 | 18% 84.25K to 99.25K | |
| 12-Oct-23 6:07 PM View: | Guy Wendy Chief Administrative Officer | Processa Pharmaceuticals, I... (PCSA) | 12-Oct-23 | Grant | 14,771 | $0.34 | $5,022.14 | 4% 354.44K to 369.21K | |
| 12-Oct-23 5:56 PM View: | Yorke Justin W Director | Processa Pharmaceuticals, I... (PCSA) | 12-Oct-23 | Grant | 6,000 | $0.30 | $1,800.00 | 1% 589.62K to 595.62K | |
| 12-Oct-23 6:04 PM View: | Ng George K Chief Executive Officer Director | Processa Pharmaceuticals, I... (PCSA) | 12-Oct-23 | Grant | 100,000 | $0.25 | $25,000.00 | 100% 100.0K to 200.0K | |
| 12-Oct-23 5:54 PM View: | Young David Pres. Research & Development Director 10% Owner | Processa Pharmaceuticals, I... (PCSA) | 12-Oct-23 | Grant | 155,277 | $0.29 | $45,030.30 | 9% 1.82M to 1.97M | |
| 10-Oct-23 4:51 PM View: | Stanker James H Chief Financial Officer | Processa Pharmaceuticals, I... (PCSA) | 10-Oct-23 | Grant | 22,500 | $0.24 | $5,400.00 | 36% 61.75K to 84.25K | |
| 10-Oct-23 5:05 PM View: | Pannu Geraldine Director | Processa Pharmaceuticals, I... (PCSA) | 10-Oct-23 | Grant | 4,500 | $0.21 | $945.00 | 8% 53.11K to 57.61K | |
| 10-Oct-23 4:58 PM View: | Yorke Justin W Director | Processa Pharmaceuticals, I... (PCSA) | 10-Oct-23 | Grant | 12,000 | $0.21 | $2,520.00 | 2% 577.62K to 589.62K | |
| 10-Oct-23 4:56 PM View: | Ng George K Chief Executive Officer Director | Processa Pharmaceuticals, I... (PCSA) | 10-Oct-23 | Grant | 100,000 | $0.25 | $25,000.00 | 100% 0 to 100.0K | |
| 10-Oct-23 5:03 PM View: | Young David Pres. Research & Development Director 10% Owner | Processa Pharmaceuticals, I... (PCSA) | 10-Oct-23 | Grant | 142,000 | $0.24 | $34,080.00 | 8% 1.68M to 1.82M | |
| 10-Oct-23 5:00 PM View: | Lin Patrick Chief Business - Strategy Off | Processa Pharmaceuticals, I... (PCSA) | 10-Oct-23 | Grant | 13,700 | $0.21 | $2,877.00 | 3% 450.83K to 464.54K | |
| 24-Jul-23 6:33 PM View: | Thompson Virgil Director | Processa Pharmaceuticals, I... (PCSA) | 27-Jun-23 | Option Exercise Duplicate | 23,636 | -- | -- | 20% 116.91K to 140.54K | |
| 24-Jul-23 6:38 PM View: | Neal James R Director | Processa Pharmaceuticals, I... (PCSA) | 27-Jun-23 | Option Exercise | 14,407 | -- | -- | 100% 0 to 14.41K | |
| 24-Jul-23 6:35 PM View: | Yorke Justin W Director | Processa Pharmaceuticals, I... (PCSA) | 27-Jun-23 | Option Exercise | 23,636 | -- | -- | 4% 552.98K to 576.62K | |
| 24-Jul-23 6:29 PM View: | Baluch Khoso Director | Processa Pharmaceuticals, I... (PCSA) | 27-Jun-23 | Option Exercise | 15,455 | -- | -- | 124% 12.5K to 27.95K | |
| 24-Jul-23 6:26 PM View: | Pannu Geraldine Director | Processa Pharmaceuticals, I... (PCSA) | 27-Jun-23 | Option Exercise | 23,636 | -- | -- | 80% 29.48K to 53.11K | |
| 12-Jun-23 4:31 PM View: | Young David President & CEO Director 10% Owner | Processa Pharmaceuticals, I... (PCSA) | 12-Jun-23 | Private Purchase | 40,000 | $0.80 | $32,000.00 | 2% 1.64M to 1.68M | |
| 14-Apr-23 6:16 PM View: | Young David President & CEO Director 10% Owner | Processa Pharmaceuticals, I... (PCSA) | 14-Apr-23 | Private Purchase | 20,000 | $0.55 | $10,998.00 | 1% 1.62M to 1.64M | |
| 13-Apr-23 4:51 PM View: | Young David President & CEO Director 10% Owner | Processa Pharmaceuticals, I... (PCSA) | 13-Apr-23 | Purchase | 20,000 | $0.48 | $9,600.00 | 1% 1.6M to 1.62M | |
| 13-Apr-23 4:51 PM View: | Young David President & CEO Director 10% Owner | Processa Pharmaceuticals, I... (PCSA) | 12-Apr-23 | Purchase | 20,000 | $0.45 | $9,000.00 | 1% 1.58M to 1.6M |
